Gavreto is recommended as a first-line treatment for metastatic RET fusion-positive, metastatic non-small cell lung cancer, ...

Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet ...

Radiotherapy may leave behind microscopic cancer even when scan images suggest the tumour is gone, and this “residual disease ...

Parasitic diseases are still the primary diseases that seriously threaten human health and life, and liver pathology is the leading cause of morbidity and ...

While radiotherapy is a highly effective cancer treatment — useful for about 60 per cent of all cancers — it may lead to ...

"The findings uncover a new way in which the immune system is suppressed, limiting T cells from fighting cancer spread. This ...

Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

Tribune raises EUR 37 million in seed and Series A funding to advance portfolio of therapies targeting central drivers of ...

Programs address the need for disease-modifying therapies targeting root causes of fibrosis Funding will support advancement of CCN-family inhibitor TRX-44 into clinical trials for treatment ...

Researchers discovered a mechanism after acute liver damage occurs—and it could lead to treatments for those with severe ...